| Keywords: |
constipation; dose response; adjuvant therapy; neoplasms; palliative care; pain; nausea; methylphenidate; opiate; sedation; bisphosphonic acid derivative; calcitonin; cancer pain; drug effect; pethidine; drug therapy, combination; paracetamol; nonsteroid antiinflammatory agent; anti-inflammatory agents, non-steroidal; drug dependence; methadone; morphine; analgesics, opioid; analgesics; anticonvulsive agent; corticosteroid; levomepromazine; drug tolerance; intravenous drug administration; analgesic agent; mexiletine; oxycodone; oral drug administration; tricyclic antidepressant agent; intramuscular drug administration; dexamphetamine; codeine; dextropropoxyphene; levodopa; subcutaneous drug administration; human; priority journal; article; sublingual drug administration
|
